Chelsea R. Parker Harp

Author

Washington University in St. Louis ORCID

Also Known As

Chelsea Parker, Chelsea Parker Harp, Chelsea R Parker, Chelsea R Parker Harp, Chelsea R. Parker, Chelsea R. Parker Harp

Publications

449

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Biogen (United States)

About

Chelsea R. Parker Harp is an author at Washington University in St. Louis specializing in autoimmunity, autoimmune disease, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	314
2	Immunology	5	5	314
3	Cell Biology	3	3	131
4	Neurology	2	2	108
5	Allergy	1	1	21

Chelsea R. Parker Harp

Publications

434

Citations

H-Index

Page 1

	Year	Citations
Intrinsic CD4+ T cell sensitivity and response to a pathogen are set and sustained by avidity for thymic and peripheral complexes of self peptide and MHC Stephen P. Persaud, Chelsea R. Parker Harp, Wan‐Lin Lo, Nature Immunology Autoimmune DiseaseAdaptive Immune SystemT-regulatory CellPathogenesisImmunology	2014	172
B Cell Antigen Presentation Is Sufficient To Drive Neuroinflammation in an Animal Model of Multiple Sclerosis Chelsea R. Parker Harp, Angela S. Archambault, Julia Sim, The Journal of Immunology Inflammatory DemyelinationImmunologyImmune RegulationCd4 T Cell ResponsesImmunotherapy	2015	97
MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response Kathryn Pellerin, Stephen Rubino, Jeremy C. Burns, Brain	2021	59
Neutrophils promote VLA-4–dependent B cell antigen presentation and accumulation within the meninges during neuroinflammation Chelsea R. Parker Harp, Angela S. Archambault, Matthew D. Cheung, Proceedings of the National Academy of Sciences	2019	47
B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis Chelsea R. Parker Harp, Angela S. Archambault, Julia Sim, PLoS ONE Lymphocyte DevelopmentAdaptive Immune SystemImmunologyImmunologic MechanismAntigen Processing	2018	21
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis Martin Himmelbauer, Bekim Bajrami, Rebecca Basile, Journal of Medicinal Chemistry	2024	14
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model Scott M. Wemlinger, Chelsea R. Parker Harp, Bo Yu, The Journal of Immunology ImmunologyPathologyImmunologic MechanismB Cell DevelopmentAntigen Processing	2022	13
Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases Gregory F. Wu, Chelsea R. Parker Harp, Kenneth S. Shindler Current Immunology Reviews Neurological DisorderImmunologyImmune RegulationInnate ImmunityImmune System	2015	11

Page 1